| Document |
Document Title |
|
WO/2024/055843A1 |
A method for detecting novel coronavirus on the basis of receptor binding. The method comprises: using cross-linked agarose as a matrix, and performing surface modification with carboxyl on same to then obtain magnetic agarose microspher...
|
|
WO/2024/059851A1 |
Some aspects of this invention provide engineered microbes for oil production. Methods for microbe engineering and for use of engineered microbes are also provided herein. In some embodiments, microbes provided are engineered to produce ...
|
|
WO/2024/059632A1 |
This disclosure provides expression systems comprising secretion signals that promote production and/or secretion of proteins of interest, as well as one or more polynucleotides encoding chaperone proteins (e.g., CRT and/or PDIA3) which,...
|
|
WO/2024/050590A1 |
The present invention provides compositions comprising microbial biomass and one or more branched chain fatty acids, as well as food products, beverage products or feedstuffs comprising microbial biomass and one or more branched chain fa...
|
|
WO/2024/050588A1 |
The present invention provides compositions comprising microbial biomass, and food products, beverage products or feedstuffs comprising microbial biomass. Desribed herein are the uses of said compositions and food products, beverage prod...
|
|
WO/2024/054236A1 |
Immobilized proteases for activation of the zymogen form of transglutaminase are disclosed.
|
|
WO/2024/050928A1 |
Disclosed in the present invention is a method for preparing pyrrolidone. Provided in the present invention is a method for preparing pyrrolidone from γ-aminobutyric acid under the catalysis of carnitine-CoA ligase CaiC. The amino acid ...
|
|
WO/2024/051151A1 |
Provided is high-efficiency silicon-releasing Streptomyces CS13-6, with an accession number of CGMCC No. 25523. The bacterial strain has relatively high silicon release, phosphate solubilization and potassium mobilization, nitrogen fixat...
|
|
WO/2024/051249A1 |
The present application provides a lysophosphatidylcholine acyltransferase for improving an EPA content, a nucleic acid molecule, and use thereof. Provided is a lysophosphatidylcholine acyltransferase (PtLPCAT) from Phaeodactylum tricorn...
|
|
WO/2024/050591A1 |
The present invention provides a method of producing a composition capable of producing a food-like aroma and/or flavour when heated, comprising a) disrupting a Mortierella spp. biomass comprising phospholipids; b) fractionating the disr...
|
|
WO/2024/050589A1 |
The present invention provides compositions comprising microbial biomass, one or more lactones and/or one or more 4-hydroxy fatty acids, as well as food products, beverage products or feedstuffs comprising microbial biomass, one or more ...
|
|
WO/2024/046489A1 |
Provided are a cutinase mutant and the use thereof in the efficient degradation of PET. The amino acid sequence of the cutinase mutant is as shown in SEQ ID NO.2, where phenylalanine at position 239 of the amino acid sequence of the wild...
|
|
WO/2024/049307A1 |
The present disclosure provides microbial strains, including fungal and yeast strains, which are useful for protein expression. Also provided are expression constructs, expression systems, growth media, and methodology for achieving expr...
|
|
WO/2024/046168A1 |
Provided are a Lactobacillus brevis strain and anti-cervical cancer use thereof. The provided Lactobacillus brevis is specifically (Lactobacillus brevis) YNH, which is deposited under CGMCC No. 24368 at the China General Microbiological ...
|
|
WO/2024/045207A1 |
The present invention relates to the technical field of polysaccharides. Disclosed are an auricularia auricula polysaccharide, use thereof, and a preparation method therefor. Auricularia auricula, after de-fatting, undergoes initial enzy...
|
|
WO/2024/045683A1 |
The present invention relates to the technical field of biological detection and particularly to a universal probe, a primer probe group, use, and a kit. Provided is a universal probe. From the 5' end to the 3' end, the universal probe c...
|
|
WO/2024/047590A1 |
This invention relates generally to particles comprising a bioactive agent embedded in a biofilm, wherein the biofilm is embedded in a matrix. More specifically, but not exclusively, it relates to particles comprising a biofilm-forming m...
|
|
WO/2024/045430A1 |
The present invention relates to the technical field of biological functions of proteins, and specifically relates to a polypeptide, a fused polymer protein and the use thereof. The polypeptide is selected from: (1) a polypeptide that ha...
|
|
WO/2024/049207A1 |
The present invention relates to a novel microorganism, a lysate thereof, a culture broth thereof, an extract of the culture broth, vesicles therefrom, and anti-inflammatory and/or antibacterial uses thereof. A novel strain and vesicles ...
|
|
WO/2024/047015A1 |
The present invention relates to a method for converting sucrose comprised in a liquid food product into at least one fructooligosaccharide (FOS), the method comprising contacting said liquid food product with an Aspergillus niger fructo...
|
|
WO/2024/045620A1 |
The present invention relates to a recombinant strain for producing 2'-fucosyllactose, a construction method, and use, and pertains to the technical field of genetic engineering. The recombinant strain and the construction method therefo...
|
|
WO/2024/046404A1 |
A recombinant botulinum toxin and a preparation method therefor. By designing and optimizing the heavy chain and light chain sequences of the recombinant botulinum toxin, adding and cleaving protein tags will not introduce amino acid res...
|
|
WO/2024/046403A1 |
The present invention relates to the technical field of molecular biology, and in particular to an adeno-associated virus structural plasmid capable of improving adeno-associated virus titer, which is provided with a Rep gene expression ...
|
|
WO/2024/045153A1 |
Provided is a method for improving the expression level of a recombinant human albumin, which comprises expressing the recombinant human albumin, and weakening, destroying or removing the function of at least one endogenous gene encoding...
|
|
WO/2024/047002A1 |
The present invention relates to provision of bacteria for promoting plant health under abiotic stress conditions, such as high salinity. In particular, the present invention relates to provision of bio-stimulant derivative Bacillus vele...
|
|
WO/2024/044810A1 |
A compound of Formula (I) when used for inhibiting nitrification: wherein: R1 is CH2CΞCH; R2 is methyl; and R3 is H.
|
|
WO/2024/040894A1 |
The present application provides a preparation method for biosynthesis of a human body structural material. A polypeptide has the amino acid sequence of SEQ ID NO. 4, 5 or 6. Recombinant type-VII humanized collagen prepared in the presen...
|
|
WO/2024/041612A1 |
Provided is an orthopoxvirus mRNA vaccine which can induce a strong body fluid immune response specific for the monkey poxvirus, induce a strong body fluid and/or T cell immune response specific to the orthopoxvirus, and induce generatio...
|
|
WO/2024/043739A1 |
The present invention relates to a novel Eutreptiella sp. strain and a method for producing fatty acids by using same and, more specifically, to: an Eutreptiella sp. strain having the ability to produce fatty acids; and a method for prod...
|
|
WO/2024/041228A1 |
The present invention relates to the technical field of microbial fermentation, and in particular to a feed liquid for the production of polysialic acid, and a preparation method for the polysialic acid. By means of investigating the kin...
|
|
WO/2024/041031A1 |
The present invention relates to a bacterial continuous evolution system, an orthogonal error-prone DNA polymerase, and a continuous evolution method. According to the present invention, after an orthogonal DNA replication system is comb...
|
|
WO/2024/037604A1 |
Provided are a Mycobacterium sp., a method for isolating same, and use thereof. The preservation number of the Mycobacterium sp. is CGMCC No. 21272 or CGMCC No. 21273. The Mycobacteria sp. has significant nitrogen fixation, carbon fixati...
|
|
WO/2024/037192A1 |
Provided a strain of Rhodotorula capable of efficiently degrading ethyl carbamate and use thereof. The present invention pertains to the technical field of food biology. Provided is a Rhodotorula strain DL-XSY01, which is capable of effi...
|
|
WO/2024/039163A1 |
The present invention relates to a novel Schizochytrium sp. strain containing a high protein content, antioxidant pigments and omega-3 fatty acids, and a method for producing a biomass containing a high protein content, antioxidant pigme...
|
|
WO/2024/039254A1 |
The vaccine disclosed herein enhances the growth parameters of Brassicaceae plants and can be used for biotization of Brassicaceae plants and for production of fully developed plant seedlings, e.g. for their direct sale.
|
|
WO/2024/039229A1 |
The present invention relates to: novel lactic acid bacteria, Lactococcus lactis P32 (KCCM13222P) and Bifidobacterium bifidum P45 (KCCM13223P), or a mixture thereof; and uses thereof. Strains and a mixture thereof, according to the prese...
|
|
WO/2024/037588A1 |
Provided are a Weizmannia coagulans capable of inhibiting the activity of alpha-glucosidase and/or alpha-amylase and use thereof. A Weizmannia coagulans SA9 strain is preserved in Guangdong Microbial Culture Collection Center on June 6, ...
|
|
WO/2024/040180A1 |
Provided herein are dairy-like analogue compositions and the methods of making the same using one or more recombinant proteins.
|
|
WO/2024/039287A1 |
The present invention relates to a method of treating organic waste comprising the steps of: treating the organic waste with a microorganism composition comprising the following microorganism species: Niallia sp., Stenotrophomonas sp. an...
|
|
WO/2024/038980A1 |
The present invention relates to Lactobacillus plantarum KU15120 strain and a use thereof. The (Lactobacillus plantarum KU15120 strain was found to have antioxidative and anti-obese effects, which led to the present invention.
|
|
WO/2024/040001A1 |
Disclosed herein are genetically engineered yeast cells capable of producing ethanol. The genetically engineered yeast cells comprise an exogenous polynucleotide sequence encoding a glyceraldehyde-3-phosphate dehydrogenase (gapN) enzyme ...
|
|
WO/2024/039850A1 |
A method of producing fungal spores utilizing solid-state fermentation (SSF), the method including steps of combining, in a solid-state fermentation vessel, fungal spores and a solid substrate to produce a fungal culture; subjecting the ...
|
|
WO/2024/032012A1 |
Provided are a phenylalanine ammonia lyase mutant, an encoding gene thereof, a genetically engineered microorganism, and a method for preparing the phenylalanine ammonia lyase mutant. Also provided is use of the phenylalanine ammonia lya...
|
|
WO/2024/035661A1 |
This disclosure provides for an improved method of stabilizing spray-dried bacterial extracts with a composition comprising a stabilizer such that the extracts can be used in cell-free protein synthesis. Also provided herein are formulat...
|
|
WO/2024/032145A1 |
The present invention relates to the field of genetic engineering, and particularly, to a novel sterilization method for accurately and efficiently killing drug-resistant bacteria by means of the combination of CRISPR and a conjugated to...
|
|
WO/2024/032452A1 |
Provided is a Lactiplantibacillus plantarum 1-D1 strain and a use thereof. The strain features genetic stability, no pathogenic/virulent genes, good safety and strong antimicrobial ability to pathogenic microorganisms, and can reduce vag...
|
|
WO/2024/031508A1 |
The present invention relates to a method for detecting multiple target nucleic acids, and in particular, to a method for achieving rapid detection and simultaneous typing of various pathogenic microorganisms by utilizing digital magneti...
|
|
WO/2024/032512A1 |
The present invention relates to the technical field of reverse transcriptase mutants, and specifically, to a reverse transcriptase, a nucleic acid molecule, and a method for synthesizing a cDNA. By introducing mutations into the amino a...
|
|
WO/2024/032360A1 |
The present invention relates to the technical field of veterinary biological products, and specifically, to a lumpy skin disease virus strain, an inactivated vaccine prepared from the strain, and a method for preparing the vaccine. The ...
|
|
WO/2024/035336A1 |
The invention relates to a method of producing a Jasmonate using a fungal cell wherein the expression of the polyketide synthase (PKS) gene has been disrupted in the fungal cell. In one embodiment, the fungal cell is yeast cell Malassezi...
|
